ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
TwoStep Therapeutics secured $62.5 million in funding. The company develops targeted cancer therapies using a proprietary bispecific antibody platform designed to activate within the tumor microenvironment.
Tap to vote and see what everyone thinks.
Summary by ByteBrief